Amy Tiersten, MD
Internal Medicine, Cancer (Oncology)
About Me
Dr. Tiersten sees patients in the Dubin Breast Center. She works collaboratively with Mount Sinai breast surgeons, radiation oncologists, radiologists, and other related subspecialists to provide care to breast cancer patients and conduct breast cancer research. Dr. Tiersten has extensive experience participating clinical trials, as well as being the Principal Investigator for national studies.
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
Research Topics
Anti-Tumor Therapy
About Me
Dr. Tiersten sees patients in the Dubin Breast Center. She works collaboratively with Mount Sinai breast surgeons, radiation oncologists, radiologists, and other related subspecialists to provide care to breast cancer patients and conduct breast cancer research. Dr. Tiersten has extensive experience participating clinical trials, as well as being the Principal Investigator for national studies.
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
Research Topics
Anti-Tumor Therapy
Clinical Focus
- Breast Cancer
- Gynecologic Cancers
Video
Education
MD, nyusm
BA, Barnard College/Columbia University
Residency, Internal Medicine
Mount Sinai Hospital
Fellowship, Hematology & Oncology
Memorial Sloan-Kettering Cancer Center
Awards
2005
New award
New York University School of Medicine, Division of Oncology
2000
New award
Columbia University College of Physicians & Surgeons
1996
New award
American Society of Clinical Oncology
Locations
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Patients with Cigna Medicare Advantage or Humana Medicare Advantage insurance: Please read this important message before booking to find out if out-of-network costs may apply to your next visit.
- Dubin Breast Center1176 Fifth Avenue, 1st Floor, New York, NY, 10029
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Patterns in use and tolerance of adjuvant neratinib in patients with hormone receptor (HR)-positive, HER2-positive early-stage breast cancer. Julia Blanter, Elena Baldwin, Rima Patel, Tianxiang Sheng, Amy Tiersten. Breast Cancer Research and Treatment
- Correlating Predicted Adjuvant Therapy Benefit and Risk of Recurrence Between Breast Cancer Index (BCI) and the 21-Gene Oncotype DX Recurrence Score (RS). Nicole Casasanta, Rima Patel, Samantha Raymond, Melanie W. Kier, Julia Blanter, Sophie Sohval, Malin Hovstadius, Catherine Wu, Brittney Zimmerman, Krystal Cascetta, Emilia Bagiella, Amy Tiersten. Clinical Breast Cancer
- Monitoring of estradiol levels in premenopausal women receiving adjuvant abemaciclib and ovarian function suppression. Alaina J. Kessler, Rima Patel, Emily Jane Gallagher, Tianxiang Sheng, Damodara Rao Mendu, Amy Tiersten, Paula Klein, Aarti S. Bhardwaj, Anupama Goel, Joseph A. Sparano, Theresa Shao, Julie Fasano. Breast Cancer Research and Treatment
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Tiersten during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Abramson, Brown & Dugan, P.A.
- ross feller casey
- kaveny kroll law firm
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Tiersten during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Abramson, Brown & Dugan, P.A.
- ross feller casey
- kaveny kroll law firm
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.